National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer.

[1]  O. Bratt.  CRITICAL ASSESSMENT OF THE EUROPEAN ASSOCIATION OF UROLOGY GUIDELINE INDICATIONS FOR PELVIC LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY , 2012, BJU international.

[2]  F. Montorsi,et al.  A population‐based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy , 2012, BJU international.

[3]  U. Capitanio,et al.  Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. , 2012, European urology.

[4]  F. Montorsi,et al.  A critical assessment of the value of lymph node dissection at radical prostatectomy: A population‐based study , 2011, The Prostate.

[5]  M. Kattan,et al.  How to tell if a new marker improves prediction. , 2011, European urology.

[6]  Guilherme Godoy,et al.  Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. , 2011, European urology.

[7]  F. Sato,et al.  [Pelvic lymph node dissection in prostate cancer]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[8]  N. Mottet,et al.  EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease - Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado , 2011 .

[9]  Thomas Wiegel,et al.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. , 2011, European urology.

[10]  F. Montorsi,et al.  Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. , 2010, European urology.

[11]  U. Studer,et al.  The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. , 2008, European urology.

[12]  C. Roehrborn,et al.  Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin , 2007, BJU international.

[13]  A. D'Amico,et al.  Guideline for the management of clinically localized prostate cancer: 2007 update. , 2007, The Journal of urology.

[14]  F. Montorsi,et al.  Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. , 2007, Urology.

[15]  Andrea Salonia,et al.  Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. , 2006, European urology.

[16]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  F. Montorsi,et al.  Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer , 2006, BJU international.

[18]  B. Konety,et al.  Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. , 2006, Urology.

[19]  P. Scardino,et al.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. , 2006, The Journal of urology.

[20]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[21]  Victor Reuter,et al.  A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. , 2003, The Journal of urology.

[22]  F. Burkhard,et al.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? , 2003, The Journal of urology.

[23]  Pierre I Karakiewicz,et al.  Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. , 2003, European urology.

[24]  Sam S. Chang,et al.  Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. , 2003, The Journal of urology.

[25]  M. Resnick,et al.  The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required? , 2002, The Journal of urology.

[26]  A. Heidenreich,et al.  Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. , 2002, The Journal of urology.